Article
Merck discontinues some cancer drug development with China's Sichuan Kelun
Rating:
0.0
Views:
43
Likes:
1
Library:
1
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value